EMAIL THIS PAGE TO A FRIEND

Cancer research

MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.


PMID 29263152

Abstract

The immune checkpoint ligand PD-L1 and the transmembrane mucin MUC1 are upregulated in triple-negative breast cancer (TNBC), where they contribute to its aggressive pathogenesis. Here, we report that genetic or pharmacological targeting of the oncogenic MUC1 subunit MUC1-C is sufficient to suppress PD-L1 expression in TNBC cells. Mechanistic investigations showed that MUC1-C acted to elevate